There is a lot of outrage that the new Alzheimer’s drug donanemab is being refused on the NHS. But there are good reasons for ...

Talk to your healthcare provider about the best way to feed your baby while ... facts-and-figures.pdf [2] FDA Converts Novel Alzheimer's Disease Treatment to Traditional Approval.

“If there is a chance this will slow the progression, that’s the best ... most early treatments focused on treating Alzheimer’s symptoms, research has turned more to the disease’s ...

A recent study suggests that a drug approved for the treatment of seizures may also help treat Alzheimer's in people who do ...

Lexeo Therapeutics said Wednesday that it received positive data for its Alzheimer's disease treatment, which suggests that higher doses improved results. The clinical-stage genetic medicine company ...

The medical community remains committed to improving treatment for those living with Alzheimer’s and other forms of dementia.

Researchers from Drexel University’s College of Nursing and Health Professions recently published a study in Biological Research For Nursing examining symptoms, health outcomes and physical function ...

Chardan Capital analyst Keay Nakae reiterated a Buy rating on Coya Therapeutics, Inc. (COYA – Research Report) today and set a price ...

What Causes Alzheimer’s Disease? Researchers don't know exactly ... which are also linked to Alzheimer’s. Sleep apnea treatment could help lower your risk of Alzheimer’s.

Sinaptica Therapeutics, Inc., a clinical-stage company leading the development of a new class of personalized neuromodulation therapeutics to treat Al ...

Alzheimer’s disease may cause ... but early diagnosis and treatment may help improve cognitive function and quality of life, as well as slow down disease progression. Some ways to help slow ...

Rensselaer Polytechnic Institute (RPI) has been awarded two grants by the National Institute on Aging (NIA) to train graduate ...